All News
Supreme Court likely to preserve access to abortion drug Mifepristone
March 27, 2024
Julia Strasser spoke with FOX5 DC about the issues raised by Supreme Court justices in the medication abortion case.
Early Inadequate Childcare is Associated with Later Poor Maternal Health, Study Finds
March 26, 2024
The Editor's Choice study in the March/April Women's Health Issues addresses the relationship between childcare precarity and maternal mental health.
In abortion pill case, US high court may undermine drug regulator
March 25, 2024
Liz Borkowski told AFP about the potential consequences should the Supreme Court decide to interfere in FDA's scientific determinations on mifepristone.
How A Shortage Of Healthcare Workers Complicates Contraceptive Access
March 11, 2024
Julia Strasser spoke to Upstream USA about the importance of provider distribution in ensuring access to contraceptive care.
Is the Constitution Bad for Your Health? Symposium Will Feature Jacobs Institute Speakers
March 8, 2024
Sara Imershein, Julia Strasser, and Sonia Suter will speak about the reproductive health and rights at a symposium on March 22, 2024.
Conservatives Gear Up for EPA Revamp in 2025
February 26, 2024
Liz Borkowski responded to plans to change how EPA operates.
Texas fights Biden over saving the life of mothers during crisis pregnancies
January 24, 2024
Sara Rosenbaum spoke to Texas Public Radio about abortion and the EMTALA law.
Hospital Maternity Units are Closing across Michigan
January 12, 2024
Julia Strasser explained to the Michigan Independent how national trends in maternity providers play out in states like Michigan.
EPA to Unveil Scientific Integrity Plan Soon. Will it Work?
January 11, 2024
Liz Borkowski discussed EPA's draft scientific integrity plan with E&E News.
Gibbs Leadership Prize: Best Manuscripts of 2023 in Women’s Health Issues
December 18, 2023
The 2023 Gibbs Prize has been awarded to authors of two studies that address substance use during pregnancy.
Is abortion access in peril (even where it's legal)? Supreme Court case could tip balance.
December 14, 2023
Sara Rosenbaum told USA Today that if the Supreme Court rules against FDA's current mifepristone rules, it “would be the equivalent of a nationwide ban.”
Abortion Pill Access Threatened as Justices Take Narrow Appeal
December 14, 2023
Sara Rosenbaum told Bloomberg Law that the Supreme Court could decide the medication abortion case by determining that the plaintiffs don’t have standing.